))
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
…
continue reading
A podcast to share the tools, tips, tricks and routines of the best biotech executives in the industry in order to help develop the next generation of biotech leaders and expedite the launch of new therapies and transform the lives of patients' all over the world.
…
continue reading
We're seeing a revolution in how we protect our data and systems, driven by rapidly evolving threats and the need for more sophisticated defenses. Our guest, Kelly Randis, Head of Global Information Technology at Gamida Cell Ltd., brings over three decades of IT expertise, primarily in the pharmaceutical industry. We discuss how AI is reshaping sec…
…
continue reading
Science isn't just about discovery; it's about doing it right to ensure reliability and validity. Joining me is Jonathon Hill, an epitome of a scientist, educator, innovator, and the Co-founder and Vice President of Science and Technology at Wasatch Biolabs. Although trained initially as a premed, Jonathon's professional journey took a deep dive in…
…
continue reading
The intersection of data and artificial intelligence forms the cornerstone of today's healthcare innovation, transforming the way we approach medical advancements. In this week’s episode, I'm excited to welcome Keshia Maughn from STATinMED, a company carving out its space with a focus on specialized data solutions in biotech. We look at the nuances…
…
continue reading
How do today’s biotech companies cultivate innovation and harness digital tools for strategic growth? In this episode, we dissect the pivotal role that digital enterprise capabilities play in transforming a company's approach to challenges in the life sciences sector. As I chat with Matt Lasmanis, Chief Technology & Innovation Officer at Sage Thera…
…
continue reading
The diverse applications of artificial intelligence are transforming industries at an unprecedented pace, but with great breakthroughs come complex challenges. Today I'm joined by Rajvir Madan, Chief Digital and Technology Officer at Arcutis Biotherapeutics, to break down the transformative impact AI is having in our field. Our discussion spans fro…
…
continue reading
The intersection of healthcare and technology paves the way for revolutionary patient care, shaping the future with precision and personalization. Today, the spotlights are on how getting data ready for AI applications is changing the game in healthcare. I'm thrilled to welcome Christopher J Kouzios, the Principal Owner of Kooz Technologies, an exp…
…
continue reading
How do we navigate the complexities of workforce management in the era of artificial intelligence? Today's discussion sheds light on the intricacies of HR policies as they adapt to the technological advancements in AI. I’m joined by Bill Pierce, Chief Information Officer at BioIVT, a visionary in leveraging technology to enhance business processes.…
…
continue reading
The impact of AI on data management, particularly in the realm of biotechnology, is undeniable. It has fundamentally transformed how we approach and utilize vast amounts of data in this field. Joining me is Elisabeth Schwartz, the IT Head at Phathom, to explore the crucial task of preparing data for AI applications and the hurdles we face in ensuri…
…
continue reading
The convergence of technology and business savvy is reshaping the biotech landscape. Today's leaders are adept at harnessing IT to drive profitability and impact lives, turning data and innovation into strategic gold. In this episode, I sit down with Eduard De Vries, a visionary at the intersection of IT and healthcare business strategy. Eduard sha…
…
continue reading
A revolution in biotechnology is underway, with artificial intelligence at its core, but the fervor over AI adoption brings with it pressing concerns about data protection that cannot be overlooked. In this episode, I'm joined by Bob McCowan, Chief Information Officer at Regeneron, to navigate the crossroads of AI development and data security. We …
…
continue reading
Automation has become a pivotal force in the advancement of the biotech sector, ushering in a new era of AI-driven solutions. In this episode, I'm joined by David Williamson, the CIO at Abzena and a trailblazer in biotech innovation. We're peeling back the layers of AI integration, from commercial chatbots that defy the conventional, to AI's grip o…
…
continue reading
Welcome to the first episode of the Biotech Bytes podcast! Today, we have an insightful conversation with Bill Wallace from Intercept Pharmaceuticals, exploring the transformative role of AI in the pharmaceutical and biotech industries. Bill talks about how working together and keeping data safe are key in these industries. He dives into the specif…
…
continue reading
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical ind…
…
continue reading
Our expert panel of C-level executives and board members reveal their tips tricks for successful late stage funding rounds. Great insight from: Hari Pujar - Operating Partner at Flagship Therapeutics and COO at Tessera Therapeutics Randy Berholtz - Chair and Chief Executive Officer Chair and Chief Executive Officer - Rancho Santa Fe Bio, Inc. Kamee…
…
continue reading
1
Best Practice for Early Stage VC Funding. Brian McVeigh, Doug Carlson, Mike Tusche
1:00:44
1:00:44
Αναπαραγωγή αργότερα
Αναπαραγωγή αργότερα
Λίστες
Like
Liked
1:00:44
Our expert panel of hugley successful biotech C-leaders jump into best practices to ensure successful early fund raises in the biotech space. Having raised 100's of millions of dollars between them this is a great listen for all of those joining the fundraising roadshow. Doug Carlson - Cheif Operating and Financial Officer - Avenge Bio Mike Tusche …
…
continue reading
Our expert panel of exceptional leaders break down the top 5 traits that all high performing CMC teams have and those areas that are critical to focus on to ensure best results. Panel members: Mike Kamarck - Chairman of Sanofi, Biologics Board Al Boyle - CTO of Alnylam JD Mowery - COO, Treadwell Therapeutics Hosted by Jared Green and Alex Cooke fro…
…
continue reading
1
The challenges of exponential growth on culture - Kristin "KG" Gustafson, Former SVP HR Kite Pharma
54:01
In this interview, KG and I discuss the cultural and leadership challenges that biotech companies face as they go through exponential growth. Drawing upon her experiences at Intercept Pharmaceuticals, Kite Pharmaceuticals and Turnstone Biologics she shares great insight into HOW companies can better serve and prepare themselves for growth.…
…
continue reading
1
The journey from HR to GM / Site Head - Carson Sublet
1:13:42
1:13:42
Αναπαραγωγή αργότερα
Αναπαραγωγή αργότερα
Λίστες
Like
Liked
1:13:42
A wide ranging interview with Carson Sublett who provides his perspective on what it takes to make it as a successful leader in the Biotech industry today. We cover how he was able to transition from HR to Site Head by creating and empowering his teams.Από τον Alex Cooke - Phase 3
…
continue reading
